ArticleFrontiers in oncology2025
Daily online adaptation enhances target coverage in prostate cancer radiotherapy: a retrospective analysis.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Intra-adaptational motion during online adaptive radiotherapy: analysis of couch shifts and implications for margin design.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026Article
- First dosimetric evaluation of deformable dose accumulation in human individuals.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026Article
- Development of CBCT-Guided Online Adaptive Radiotherapy.Cancers · 2026Review
- CBCT based online daily adaptive treatment improves target coverage with limited benefit for OAR protection in SBRT prostate cancer.Radiation oncology (London, England) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Online adaptive radiotherapy aims to improve treatment quality by accounting for inter-fractional variation in anatomy. This study presents a quantitative comparison between adapted and non-adapted scheduled plans with identical margins in a real-world clinical setting. Methods: We retrospectively analyzed 422 fractions from 43 patients with prostate cancer treated with the Varian Ethos system. All patients received hypofractionated treatment with 3 Gy per fraction up to a cumulative dose of 60 Gy. For each fraction, the scheduled plan (planned on planning CT, calculated on synthetic CT derived from daily cone beam CT) was compared to the adapted plan (planned and calculated on actual daily anatomy) by means of several dose-volume metrics. Comparative statistics regarding dose-volume metrics were performed using Wilcoxon signed-rank test for paired data with a two-sided hypothesis. Results: Adapted plans delivered significantly better target coverage, conformality, and homo-geneity than scheduled plans. The constraints D95% ≥ 95% and V95% ≥ 95% were met in 418 out of 422 fractions with the adapted plan, compared to only 41%-84% of fractions with the scheduled plan. Median absolute improvements for these metrics ranged between 1.5 and 6.0 percentage points. Most organ-at-risk metrics remained unchanged or showed only minor differences. Interquartile ranges decreased across all metrics. Conclusions: Adaptation significantly improved target dose metrics compared to non-adapted plans, without compromising organs-at-risk sparing. Interquartile ranges were reduced for all metrics evidencing better repeatability of adapted plans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.